Key facts
- This page summarizes Felipe MacLean's Form 4 filing for Clover Leaf Capital Corp..
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 24 Jul 2023, 17:09.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Conversion of derivative security
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Conversion of derivative security
Additional SEC filing notes
Footnote F1
The shares of Class B common stock of the Issuer are convertible into shares of Class A common stock on a one-for-one basis. The Class B common stock has no expiration date. On July 20, 2023, the reporting person elected to convert 3,457,806 shares of Class B common stock held by it into 3,457,806 shares of Class A common stock.
Footnote F2
Includes 571,859 shares of Class A common stock underlying private placement units (each unit consisting of one share of Class A common stock and one right to receive one-eighth of one share of Class A common stock upon the consummation of an initial business combination) held by Yntegra Capital Investments, LLC (the "Sponsor"), acquired in connection with the Issuer's initial public offering.
Footnote F3
The Sponsor is the record holder of the securities reported herein. Yntegra Capital Management, LLC is the sole managing member of the Sponsor, and Mr. MacLean, the Chairman and Chief Executive Officer of the Issuer, is the sole manager of Yntegra Capital Management, LLC and has voting and dispositive control over these securities. By virtue of this relationship, each of Yntegra Capital Management, LLC and Mr. MacLean may be deemed to have beneficial ownership of the securities held of record by the Sponsor. Each such person disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest they may have therein, directly or indirectly.